- 23 February 2023Portfolio NewsPrilenia Announces Topline Results for Pridopidine in Phase 2 ALS Study
- 20 February 2023SV NewsImpact funds help fight dementia and antibiotic resistance
- 16 February 2023Portfolio NewsPerfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter
- 13 February 2023Portfolio NewsCerevance Expands Series B Financing with Additional $51 Million
- 8 February 2023Portfolio NewsNimbus Therapeutics Announces Closing of Takeda's Acquisition of TYK2 Subsidiary
- 25 January 2023Portfolio NewsHPS/PayMedix Closes on $25 Million in New Funding
- 24 January 2023SV NewsBritain is losing its chance to become a life sciences superpower
- 16 January 2023SV NewsBritish Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund
- 12 January 2023Portfolio NewsFeinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial
- 9 January 2023Portfolio NewsImbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction
- 9 January 2023Portfolio NewsTRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
- 9 January 2023Portfolio NewsExclusive: Eli Lilly boosts inflammatory disease pipeline, licenses three candidates from TRexBio